4 active not recruiting, 1 terminated, 1 withdrawn. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Active not recruiting 3, Terminated 1 |
| Phase 2 | 3 | Active not recruiting 2, Withdrawn 1 |
Follow Refractory Lung Non-Small Cell Carcinoma: new trials by email Literature Review of Refractory Lung Non-Small Cell Carcinoma trials Research Report on Refractory Lung Non-Small Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer Biospecimen Collection, Cemiplimab, Cetuximab Sarotalocan Sodium - Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | Phase 2 | Withdrawn | Roswell Park Cancer Institute | 2026-08-15 | 2026-09-15 | |
| Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors Antineoplastic Immune Cell, Atezolizumab, Biospecimen Collection - Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | Phase 1 | Active not recruiting | University of California, Irvine | 6 | 2022-07-20 | 2026-10-06 |
| Necitumumab and Trastuzumab in Combination With Osimertinib for the Treatment of Refractory Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Non-small Cell Lung Cancer Necitumumab, Osimertinib, Quality-of-Life Assessment - Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Active not recruiting | Jonsson Comprehensive Cancer Center | 30 | 2021-01-29 | 2026-07-17 |
| Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors Pembrolizumab, Sonidegib - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8 | Phase 1 | Active not recruiting | Mayo Clinic | 36 | 2020-02-13 | 2026-03-18 |
| Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC Atezolizumab 1200 MG in 20 ML Injection, Stereotactic Body Radiation Therapy, Varlilumab 3 mg/kg - Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1 | Terminated | Rutgers, The State University of New Jersey | 16 | 2019-09-11 | 2026-02-05 |
| Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer Atezolizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 53 | 2018-11-29 | 2026-11-18 |
Carcinoma, Non-Small-Cell Lung (6) · Lung Neoplasms (6) · Carcinoma, Transitional Cell (1) · Melanoma (1) · Neoplasm Metastasis (1) · Squamous Cell Carcinoma of Head and Neck (1)
Bronchial Neoplasms (6) · Carcinoma, Bronchogenic (6) · Lung Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Respiratory Tract Diseases (6) · Respiratory Tract Neoplasms (6) · Thoracic Neoplasms (6) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1)
atezolizumab (3) · Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · Biopsy (1) · Cyclophosphamide (1) · Disulfides (1) · Immunoglobulin G (1) · Injections (1) · Ogivri (1) · Ontruzant (1) · PF-05280014 (1) · Photochemotherapy (1) · Radiosurgery (1) · Thoracic Surgery, Video-Assisted (1) · Trastuzumab (1)
Jonsson Comprehensive Cancer Center (1) · Mayo Clinic (1) · National Cancer Institute (NCI) (1) · Roswell Park Cancer Institute (1) · Rutgers, The State University of New Jersey (1) · University of California, Irvine (1)
United States (6)
Jonathan W Goldman (1) · Jyoti Malhotra (1) · Miguel Villalona, MD (1) · Mojun Zhu, M.D. (1) · Prantesh Jain (1) · Salma Jabbour (1) · Stephen V Liu (1)
P30CA033572 (1), P30CA072720 (1), R01CA266457 (1), UM1CA186691 (1)